MARGARET DOKU: Open Payments
NPI 1437503679 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 30 payments from 11 companies in 2025. Trend: 2023 $462 · 2024 $661 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $396 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Inspire Medical Systems, Inc. | 2 | $66 |
| Corcept Therapeutics | 2 | $53 |
| Lilly USA, LLC | 3 | $49 |
| Dexcom, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $31 |
| ABBVIE INC. | 2 | $30 |
| Abbott Laboratories | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Wegovy, Ozempic, INSPIRE, Korlym, Dexcom G6 Transmitter, BREZTRI, REXULTI, FARXIGA.
Industry payments across GA — which companies pay providers there.
